Clinical studies recruiting near Kortrijk

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · AZ Groeninge Campus Kennedylaan · Pfizer · NCT07028853 Diagnostic Accuracy of the Stepped Screening Protocol and Its Screening Tools in the Perinatal Period.
Phase N/A · AZ Groeninge · University Hospital, Ghent · NCT05961306 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · AZ Groeninge Kortrijk · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Effect of IMT in Patients After Acute Exacerbations of COPD
NA · AZ Groeninge · KU Leuven · NCT07213128 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · AZ Groeninge Campus Kennedylaan · Eli Lilly and Company · NCT06937086 A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Live
Phase 1 · Kortrijk · Bayer · NCT06764316 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Effectiveness of the Suicidal Crisis Intervention (SCI)
NA · AZ Groeninge (incl. Mobiel Crisis Team Kortrijk) · University Hospital, Ghent · NCT05638204 Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations
NA · AZ Groeninge · University Hospital, Ghent · NCT07402057 First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant
Phase 1 · AZ Groeninge Campus Kennedylaan - Urology · Bayer · NCT06217822 Synbiotics in Patients at RIsk fOr Preterm Birth
NA · AZ Groeninge · Ziekenhuis Oost-Limburg · NCT05966649 Proactive TDM Versus Standard Use of Biologics in Psoriasis
Phase 4 · Dermatologie Handelskaai · University Hospital, Ghent · NCT06398106 A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · AZ Groeninge Campus Kennedylaan · Eli Lilly and Company · NCT06119581 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site BE32002 · Astellas Pharma Global Development, Inc. · NCT02960022 Improving the Use of Immunotherapy to Treat Liver Cancer
NA · AZ Groeninge · Universitaire Ziekenhuizen KU Leuven · NCT07623265 Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Particip
Phase 3 · Investigational Site Number : 0560007 · Sanofi · NCT07325292 Follow-up and Outcome of Operative Treatment With Decompressive Release Of The Peroneal Nerve
NA · AZ Groeninge, department of neurosurgery · Universitaire Ziekenhuizen KU Leuven · NCT04695834 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
Phase 2 · AZ Groeninge · Universitaire Ziekenhuizen KU Leuven · NCT06831955 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 2805 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 SNV1521 in Participants With Advanced Solid Tumors
Phase 1 · AZ Groeninge · Synnovation Therapeutics, Inc. · NCT06220864 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · AZ Groeninge · Revolution Medicines, Inc. · NCT06881784 The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Phase 4 · AZ Groeninge · Ziekenhuis Oost-Limburg · NCT07359599 Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Phase 3 · AZ Groeninge Kortrijk · Universitaire Ziekenhuizen KU Leuven · NCT05569772 PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (
NA · AZ Groeninge Kortrijk - Campus Kennedylaan · European Organisation for Research and Treatment of Cancer - · NCT04790253 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · AZ Groeninge Campus Kennedylaan · Eli Lilly and Company · NCT06937099 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 The Dragon PLC Trial (DRAGON-PLC)
NA · AZ Groeninge Hospital Kortrijk · Maastricht University · NCT06914648

Look up another city

Look up another condition